| Literature DB >> 31472945 |
Mathieu Jamelot1, Maxime Fontanilles2, Yvan Vaschalde3.
Abstract
Entities:
Keywords: Cancer; Carboplatin-paclitaxel; Carboplatine-paclitaxel; Chemotherapy; Chimiothérapie; Leucoencéphalopathie postérieure réversible; Neurologie; Neurology; Reversible Posterior Leukoencephalopathy
Year: 2019 PMID: 31472945 DOI: 10.1016/j.bulcan.2019.06.004
Source DB: PubMed Journal: Bull Cancer ISSN: 0007-4551 Impact factor: 1.276